These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6461238)

  • 1. Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack of association with blood pressure control.
    Fouad FM; Nakashima Y; Tarazi RC; Salcedo EE
    Am J Cardiol; 1982 Mar; 49(4):795-801. PubMed ID: 6461238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular filling pattern in hypertensive patients after reversal of myocardial hypertrophy.
    Agati L; Fedele F; Penco M; Sciomer S; Dagianti A
    Int J Cardiol; 1987 Nov; 17(2):177-85. PubMed ID: 2960623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].
    Vogt M; Kreutz KU; Motz W; Strauer BE
    Z Kardiol; 1989 Jul; 78(7):469-77. PubMed ID: 2528245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel therapeutic approach for reversal of left ventricular hypertrophy and blood pressure control in hypertensive patients treated with alpha-methyldopa or propranolol.
    Fernandez PG; Snedden W; Kim BK; Lee CC
    Can J Physiol Pharmacol; 1985 Apr; 63(4):304-8. PubMed ID: 3159468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of regression of left ventricular hypertrophy in treated hypertensive patients.
    Wollam GL; Hall WD; Porter VD; Douglas MB; Unger DJ; Blumenstein BA; Cotsonis GA; Knudtson ML; Felner JM; Schlant RC
    Am J Med; 1983 Sep; 75(3A):100-10. PubMed ID: 6226186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation of changes in systolic blood pressure with regional anatomical regression of hypertensive left ventricular hypertrophy in patients on chronic antihypertensive therapy (greater than 1 year): alpha-methyldopa compared to propranolol.
    Fernandez PG; Kim BK; Reichek N; Ko P; Gill V; McDonald J; Furlong L; Lewis H; Nolan R; McManamon P
    Curr Med Res Opin; 1984; 8(10):720-33. PubMed ID: 6233093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of single-dose methyldopa and diuretic on BP and left ventricular mass.
    Weinstein M; Hilewitz H; Rogel S
    Arch Intern Med; 1984 Aug; 144(8):1629-32. PubMed ID: 6235790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac hypertrophy in hypertension.
    Cífková R; Frídl P; Skibová J; Niederle P; Widimský J
    Cor Vasa; 1990; 32(1):3-12. PubMed ID: 1971206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension.
    Drayer JI; Weber MA; Gardin JM; Lipson JL
    Am J Med; 1983 Sep; 75(3A):116-20. PubMed ID: 6226188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the effects of urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans.
    Feldstein CA; Olivieri AO; Sabarís RP
    Drugs; 1988; 35 Suppl 6():90-7. PubMed ID: 2969799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine.
    Strauer BE; Atef Mahmoud M; Bayer F; Bohn I; Motz U
    Eur Heart J; 1984 Dec; 5 Suppl F():53-60. PubMed ID: 6241903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition].
    Motz W; Strauer BE
    Z Kardiol; 1988 Jan; 77(1):53-60. PubMed ID: 2834885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of left ventricular hypertrophy in hypertension with indapamide.
    Sami M; Haichin R
    Am Heart J; 1991 Oct; 122(4 Pt 2):1215-8. PubMed ID: 1833967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diltiazem prevents hypertrophy progression, preserves systolic function, and normalises myocardial oxygen utilisation in the spontaneously hypertensive rat.
    Tubau JF; Wikman-Coffelt J; Massie BM; Szlachcic J; Parmley WW; Sievers R; Henderson S
    Cardiovasc Res; 1987 Aug; 21(8):606-14. PubMed ID: 2965615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol.
    Trimarco B; De Luca N; Rosiello G; Ricciardelli B; Betocchi S; Filardi PP; Raponi M; Condorelli M
    Am J Cardiol; 1989 Oct; 64(12):745-51. PubMed ID: 2572165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cardiac hypertrophy and left ventricular function with the calcium antagonist felodipine in hypertensive patients.
    Cerasola G; Cottone S; Nardi E; Fulantelli MA; Carone MB; D'Ignoto G
    J Hum Hypertens; 1990 Dec; 4(6):703-8. PubMed ID: 2151392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular adjustment to antiadrenergic agents.
    Pegram BL; Frohlich ED
    Am J Med; 1983 Sep; 75(3A):94-9. PubMed ID: 6137951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.